Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.39M Sell
99,422
-18,053
-15% -$472K 0.17% 116
2026
Q1
$3.3M Sell
117,475
-10,368
-8% -$276K 0.27% 85
2025
Q4
$3.18M Sell
127,843
-13,290
-9% -$335K 0.26% 84
2025
Q3
$3.6M Sell
141,133
-6,480
-4% -$160K 0.29% 85
2025
Q2
$3.58M Sell
147,613
-3,666
-2% -$85.5K 0.31% 82
2025
Q1
$3.83M Sell
151,279
-6,172
-4% -$162K 0.36% 75
2024
Q4
$4.18M Sell
157,451
-24,568
-13% -$666K 0.38% 73
2024
Q3
$5.27M Buy
182,019
+2,690
+2% +$78.5K 0.49% 59
2024
Q2
$5.02M Sell
179,329
-1,367
-0.8% -$37.6K 0.5% 57
2024
Q1
$5.01M Sell
180,696
-11,253
-6% -$312K 0.51% 58
2023
Q4
$5.53M Buy
191,949
+4,480
+2% +$135K 0.58% 52
2023
Q3
$6.22M Buy
187,469
+925
+0.5% +$32.7K 0.75% 41
2023
Q2
$6.84M Buy
186,544
+3,852
+2% +$150K 0.79% 38
2023
Q1
$7.45M Buy
182,692
+3,195
+2% +$138K 0.91% 33
2022
Q4
$9.2M Sell
179,497
-955
-0.5% -$45.8K 1.16% 21
2022
Q3
$7.9M Buy
180,452
+152,584
+548% +$7.41M 1.1% 25
2022
Q2
$1.46M Sell
27,868
-138,566
-83% -$7.06M 0.33% 61
2022
Q1
$8.62M Buy
166,434
+769
+0.5% +$39.9K 1.02% 27
2021
Q4
$9.78M Buy
165,665
+1,523
+0.9% +$75.5K 1.18% 20
2021
Q3
$7.06M Buy
164,142
+143,349
+689% +$6.35M 0.94% 29
2021
Q2
$814K Sell
20,793
-1,536
-7% -$59.7K 0.18% 103
2021
Q1
$809K Buy
22,329
+239
+1% +$8.49K 0.2% 98
2020
Q4
$813K Sell
22,090
-664
-3% -$24.4K 0.21% 94
2020
Q3
$792K Sell
22,754
-753
-3% -$26.4K 0.25% 88
2020
Q2
$729K Sell
23,507
-971
-4% -$33K 0.25% 81
2020
Q1
$758K Sell
24,478
-3,109
-11% -$106K 0.33% 74
2019
Q4
$1.02M Buy
+27,587
New +$983K 0.37% 66

Other funds holding PFE

XML Financial's PFE Position: Q2 2026 in Review

XML Financial reduced its Pfizer (PFE) stake by 15% in Q2 2026, selling an estimated $472K and leaving 99,422 shares worth $2.39M. The position accounts for 0.17% of the portfolio, ranked #116.

XML Financial first reported a position in PFE in Q4 2019 and has held it in 27 quarters since. The position peaked at $9.78M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • XML Financial held 99,422 shares of Pfizer worth $2.39M as of Q2 2026.
  • XML Financial sold 18,053 Pfizer shares in Q2 2026, an estimated $472K.
  • Pfizer made up 0.17% of XML Financial's portfolio in Q2 2026, its #116 holding.
  • XML Financial first reported a position in Pfizer in Q4 2019 and has held it in 27 quarters since.
  • XML Financial's Pfizer position peaked at $9.78M in Q4 2021.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on XML Financial's 13F filing for Q2 2026, filed 24 Jul 2026.